Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra in Prediabetes (Hyper-PreDIL)
NCT05854251Phase 2Completed
- Sponsor
- University Hospital Basel
- Start
- Jun 2023
- Primary completion
- May 2024
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of anakinra in prediabetes (2 arms), sponsored by University Hospital Basel. Primary endpoints: Change in insulin concentration following a standardized mixed-meal test, Change in glucose concentration following a standardized mixed-meal test and 2 more. Started Jun 2023; status: completed.
02
Drugs
anakinra
03
Conditions
prediabetes
Beyond the preview
Go deeper on NCT05854251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05854251.